Related Experiment Video
Updated: Aug 2, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Cellular signals integrate cell cycle and metabolic control in cancer
Chareeporn Akekawatchai1, Sarawut Jitrapakdee2
1Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand; Thammasat University Research Unit in Diagnostic Molecular Biology of Chronic Diseases related to Cancer (DMB-CDC), Pathumthani, Thailand.
Abstract:
Growth factors are the small peptides that can promote growth, differentiation, and survival of most living cells. However, aberrant activation of receptor tyrosine kinases by GFs can generate oncogenic signals, resulting in oncogenic transformation. Accumulating evidence support a link between GF/RTK signaling through the major signaling pathways, Ras/Erk and PI3K/Akt, and cell cycle progression. In response to GF signaling, the quiescent cells in the G0 stage can re-enter the cell cycle and become the proliferative stage. While in the proliferative stage, tumor cells undergo profound changes in their metabolism to support biomass production and bioenergetic requirements. Accumulating data show that the cell cycle regulators, specifically cyclin D, cyclin B, Cdk2, Cdk4, and Cdk6, and anaphase-promoting complex/cyclosome (APC/C-Cdh1) play critical roles in modulating various metabolic pathways. These cell cycle regulators can regulate metabolic enzyme activities through post-translational mechanisms or the transcriptional factors that control the expression of the metabolic genes. This fine-tune control allows only the relevant metabolic pathways to be active in a particular phase of the cell cycle, thereby providing suitable amounts of biosynthetic precursors available during the proliferative stage. The imbalance of metabolites in each cell cycle phase can induce cell cycle arrest followed by p53-induced apoptosis.
Insights
Growth factors (GFs) can drive cell proliferation by activating receptor tyrosine kinases (RTKs). Cell cycle regulators fine-tune cellular metabolism to support tumor growth, with imbalances potentially leading to apoptosis.
Area of Science:
- Cell Biology
- Molecular Oncology
- Metabolic Regulation
Background:
- Growth factors (GFs) promote cell growth, differentiation, and survival.
- Aberrant GF/receptor tyrosine kinase (RTK) signaling can lead to oncogenic transformation.
- GF/RTK signaling influences major pathways like Ras/Erk and PI3K/Akt, driving cell cycle progression.
Purpose of the Study:
- To explore the intricate relationship between cell cycle regulation and metabolic reprogramming in cancer.
- To elucidate the role of specific cell cycle regulators in modulating metabolic pathways.
- To understand how metabolic imbalances during the cell cycle contribute to cancer progression and cell fate.
Main Methods:
- Review of accumulating evidence linking GF/RTK signaling to cell cycle progression.
- Analysis of the role of key cell cycle regulators (cyclins, CDKs, APC/C-Cdh1) in metabolic control.
- Investigation of post-translational modifications and transcriptional regulation of metabolic enzymes by cell cycle regulators.
Main Results:
- GF signaling enables quiescent cells to re-enter the cell cycle and proliferate.
- Tumor cells exhibit significant metabolic changes during proliferation to meet biomass and energy demands.
- Cell cycle regulators (cyclin D, B, Cdk2, 4, 6, APC/C-Cdh1) critically control metabolic pathways.
- Metabolic enzyme activity is regulated via post-translational mechanisms or transcriptional control by cell cycle regulators.
- Precise metabolic pathway activation supports biosynthetic precursor availability during proliferation.
Conclusions:
- Cell cycle regulators orchestrate metabolic reprogramming essential for tumor cell proliferation.
- Imbalances in cellular metabolism during specific cell cycle phases can trigger cell cycle arrest and apoptosis.
- Targeting the interplay between cell cycle and metabolism presents a potential therapeutic strategy in oncology.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
What is the Cell Cycle?

